EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Therapeutic Potential of Stem Cells in Depression

Lidia Jurczenko iD, Alina Semeniuk iD, Jerzy Waldemar Leszek

International Journal of Molecular Sciences · 27.08.2025 · 26 (17) · 8306

DOI: 10.3390/ijms26178306 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.08.2025. Verfasst von Lidia Jurczenko und 2 weiteren Autor:innen. Beteiligte Einrichtung: 4th Military Clinical Hospital, ul. Rudolfa Weigla 5, 50-981 Wrocław, Poland. Hauptthemen laut MEDLINE: Major Depressive Disorder, Stem Cell Transplantation, Depression. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major depressive disorder (MDD) is a prevalent and disabling psychiatric condition with limited treatment options for patients who are resistant to conventional pharmacological and psychotherapeutic interventions. Stem cell (SC)-based therapies have emerged as a promising experimental approach, offering multifaceted mechanisms of action including neurogenesis, immunomodulation, antioxidative protection, and neuromodulation. This narrative review synthesizes current evidence from preclinical studies and early-phase clinical trials on the efficacy of mesenchymal stem cells (MSCs), neural stem cells (NSCs), and induced pluripotent stem cells (iPSCs) in alleviating depressive-like behaviors. Mechanistic insights include enhanced hippocampal neurogenesis, modulation of the brain-derived neurotrophic factor (BDNF)–TrkB pathway, attenuation of neuroinflammation through microglial polarization, and restoration of serotonergic signaling via peripheral-to-central pathways such as via the vagus nerve. In addition, the therapeutic potential of extracellular vesicles (EVs) and intranasal administration as non-invasive delivery strategies is discussed. While animal and first preclinical studies suggest potential benefit, significant translational barriers remain, including issues of scalability, long-term safety, and ethical considerations. Further rigorous studies are needed to validate stem-cell-based therapies as viable treatments for MDD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderStem Cell TransplantationDepressionHumansAnimalsNeural Stem CellsNeurogenesisInduced Pluripotent Stem CellsMesenchymal Stem Cells

Stichwörter der Autor:innen

brain-derived neurotrophic factorexosomesmajor depressive disorder (MDD)mesenchymal stem cellsneural stem cellsneurogenesisneuroinflammationoxidative stressstem cell therapytreatment-resistant depression

Autor:innen und Institutionen

  • 4th Military Clinical Hospital, ul. Rudolfa Weigla 5, 50-981 Wrocław, Poland.
  • Lower Silesian Center for Oncology, Pulmonology and Hematology, Grabiszyńska 105, 53-439 Wrocław, Poland.
  • Department of Psychiatry, Wroclaw Medical University, 50-367 Wrocław, Poland.

ORCID-Profile: Lidia Jurczenko, Alina Semeniuk

Zitieren

APA

Jurczenko, L., Semeniuk, A., & Leszek, J. W. (2025). The Therapeutic Potential of Stem Cells in Depression. International Journal of Molecular Sciences, 26(17), 8306. https://doi.org/10.3390/ijms26178306

Vancouver

Jurczenko L, Semeniuk A, Leszek JW. The Therapeutic Potential of Stem Cells in Depression. International Journal of Molecular Sciences. 2025;26(17):8306. doi:10.3390/ijms26178306

BibTeX
@article{Jurczenko2025,
  author = {Jurczenko, Lidia and Semeniuk, Alina and Leszek, Jerzy Waldemar},
  title = {The Therapeutic Potential of Stem Cells in Depression},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {17},
  pages = {8306},
  doi = {10.3390/ijms26178306}
}
Kostenlos starten →